Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06526676 · ClinicalTrials.gov registry record · NA
Clinical Outcomes and Major Adverse Events in Patients Treated With Physician-Modified Fenestrated and Branched Stent Grafts
A NA study of Thoracoabdominal Aortic Aneurysm and Juxtarenal Aortic Aneurysm, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06526676: Recruiting NA study of Thoracoabdominal Aortic Aneurysm and Juxtarenal Aortic Aneurysm, sponsored by University of California, Los Angeles.
NCT06526676 is a NA study of Thoracoabdominal Aortic Aneurysm and Juxtarenal Aortic Aneurysm that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 50 participants, below the 196-participant average among 11 other Thoracoabdominal Aortic Aneurysm trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06526676, a NA study of Thoracoabdominal Aortic Aneurysm and Juxtarenal Aortic Aneurysm, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate safety and effectiveness of endovascular treatment of juxtarenal, pararenal and thoracoabdominal aortic aneurysms (with or without iliac artery involvement) using physician-modified stent grafts with a combination of fenestrations and/or branches.
Primary Outcome
Total number of patients to experience a major adverse event as defined as any cause mortality, bowel ischemia (requiring surgical therapy), type I myocardial infarction (rise of troponin levels at least 1 value above 99th percentile of upper limit and with at least one of the following: symptoms of acute myocardial ischemia, new ischemic ECG changes, development of new pathological Q waves, imaging evidence of loss of viable myocardium or new regional wall motion abnormalities, or identificatio
Conditions Studied
Interventions
- DEVICE Cook Alpha TX2 Stent Graft, Cook Zenith TX2, and Cook Zenith Fenestrated Stent Graft
Study Locations (1)
California
- University of California, Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-12-02 |
| Est. Completion | 2032-12 |
| Phase | NA |
What NCT06526676 shows while recruiting
NCT06526676 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 196-participant average among 11 other Thoracoabdominal Aortic Aneurysm trials with a reported enrollment target (74% lower).
The record links to 3 conditions, with Thoracoabdominal Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Cook Alpha TX2 Stent Graft, Cook Zenith TX2, and Cook Zenith Fenestrated Stent Graft is the first listed.
NCT06526676 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06526676 about?
NCT06526676 is a clinical study titled "Clinical Outcomes and Major Adverse Events in Patients Treated With Physician-Modified Fenestrated and Branched Stent Grafts". The purpose of this study is to evaluate safety and effectiveness of endovascular treatment of juxtarenal, pararenal and thoracoabdominal aortic aneurysms (with or without iliac artery involvement) using physician-modified stent grafts with a combination of fenestrations and/or branches.
What is the current status of trial NCT06526676?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-12-02. Estimated completion is 2032-12.
What conditions does trial NCT06526676 study?
This clinical trial studies the following conditions: Thoracoabdominal Aortic Aneurysm, Juxtarenal Aortic Aneurysm, Pararenal Aneurysm.
What interventions are being tested in trial NCT06526676?
The interventions under investigation include: Cook Alpha TX2 Stent Graft, Cook Zenith TX2, and Cook Zenith Fenestrated Stent Graft (DEVICE).
Who is sponsoring clinical trial NCT06526676?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06526676 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thoracoabdominal Aortic Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06526676's enrollment target sits among peer trials
50 8th of 11 higher than 4 of 11 other Thoracoabdominal Aortic Aneurysm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Thoracoabdominal Aortic Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms
RECRUITING · NA
-
CAAAs, TAAAs, Aortic Arch Aneurysms or Dissections With Fenestrated/Branched Stent Graft
RECRUITING · NA
-
PMEG for Repair of Pararenal and Thoracoabdominal Aortic Aneurysm
RECRUITING · NA
-
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
RECRUITING · NA
-
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
RECRUITING · NA
-
Physician Modified Endograft For Complex Aortic Aneurysm Repair
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI